Another meta-analysis found that 80% of patients infected with SARS-CoV-2 had one or more long-term symptoms and that the top most typical symptoms were chronic fatigue (58%), headache (44%), attention problems (27%), hair loss (25%), and dyspnea (24%), although memory loss, anxiety, depression, insomnia, digestive disorders, and autonomic symptoms were also widespread (from 10 to 20%) 15110 days after virus infection [106]
Scovino AM, Totino PRR, Morrot A
Tirzepatide is the better fit when risk is stacked: significant obesity plus diabetes, MASLD, sleep apnea, or multiple cardiovascular risk factors, where the priority is maximum multimarker change in the shortest safe window. Semaglutide is the better fit when risk is moderate or the patient (or insurer) wants the longest, clearest outcome data: obesity with earlierstage cardiometabolic disease, where strong improvements and proven event reduction are enough without deploying dualagonist intensity. How Do Tirzepatide and Semaglutide Support Liver and Sleep Health
Related: Stars Who've Spoken About Ozempic and What They've Said In five months of being on the injectables, Webster reportedly lost 35 lbs
